These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 10778734

  • 1. Carboplatin therapy for optic pathway tumors in children with neurofibromatosis type-1.
    Listernick R, Charrow J, Tomita T, Goldman S.
    J Neurooncol; 1999; 45(2):185-90. PubMed ID: 10778734
    [Abstract] [Full Text] [Related]

  • 2. Carboplatin-induced regression of an optic pathway tumor in a child with neurofibromatosis.
    Charrow J, Listernick R, Greenwald MJ, Das L, Radkowski MA.
    Med Pediatr Oncol; 1993; 21(9):680-4. PubMed ID: 8413004
    [Abstract] [Full Text] [Related]

  • 3. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study.
    Listernick R, Charrow J, Greenwald M, Mets M.
    J Pediatr; 1994 Jul; 125(1):63-6. PubMed ID: 8021787
    [Abstract] [Full Text] [Related]

  • 4. Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history.
    Listernick R, Darling C, Greenwald M, Strauss L, Charrow J.
    J Pediatr; 1995 Nov; 127(5):718-22. PubMed ID: 7472822
    [Abstract] [Full Text] [Related]

  • 5. Orbital optic nerve gliomas in children with neurofibromatosis type 1.
    Zeid JL, Charrow J, Sandu M, Goldman S, Listernick R.
    J AAPOS; 2006 Dec; 10(6):534-9. PubMed ID: 17189147
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Carboplatin for the treatment of children with newly diagnosed optic chiasm gliomas: a phase II study.
    Aquino VM, Fort DW, Kamen BA.
    J Neurooncol; 1999 Feb; 41(3):255-9. PubMed ID: 10359145
    [Abstract] [Full Text] [Related]

  • 8. Carboplatin treatment of progressive optic pathway gliomas to delay radiotherapy.
    Moghrabi A, Friedman HS, Burger PC, Tien R, Oakes WJ.
    J Neurosurg; 1993 Aug; 79(2):223-7. PubMed ID: 8331404
    [Abstract] [Full Text] [Related]

  • 9. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.
    Kuenzle C, Weissert M, Roulet E, Bode H, Schefer S, Huisman T, Landau K, Boltshauser E.
    Neuropediatrics; 1994 Dec; 25(6):295-300. PubMed ID: 7770126
    [Abstract] [Full Text] [Related]

  • 10. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
    Dalla Via P, Opocher E, Pinello ML, Calderone M, Viscardi E, Clementi M, Battistella PA, Laverda AM, Da Dalt L, Perilongo G.
    Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361
    [Abstract] [Full Text] [Related]

  • 11. Development and implementation of a carboplatin desensitization protocol for children with neurofibromatosis, type 1 and hypersensitivity reactions in an outpatient oncology clinic.
    Ogle SK, Rose MM, Wildes CT.
    J Pediatr Oncol Nurs; 2002 Oct; 19(4):122-6. PubMed ID: 12203191
    [Abstract] [Full Text] [Related]

  • 12. Outcomes of systematic screening for optic pathway tumors in children with Neurofibromatosis Type 1.
    Blazo MA, Lewis RA, Chintagumpala MM, Frazier M, McCluggage C, Plon SE.
    Am J Med Genet A; 2004 Jun 15; 127A(3):224-9. PubMed ID: 15150770
    [Abstract] [Full Text] [Related]

  • 13. Phase II study of carboplatin in children with progressive low-grade gliomas.
    Gururangan S, Cavazos CM, Ashley D, Herndon JE, Bruggers CS, Moghrabi A, Scarcella DL, Watral M, Tourt-Uhlig S, Reardon D, Friedman HS.
    J Clin Oncol; 2002 Jul 01; 20(13):2951-8. PubMed ID: 12089224
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of type 1 neurofibromatosis (von Recklinghausen Disease) in childhood optic glioma.
    Deliganis AV, Geyer JR, Berger MS.
    Neurosurgery; 1996 Jun 01; 38(6):1114-8; discussion 1118-9. PubMed ID: 8727140
    [Abstract] [Full Text] [Related]

  • 15. Childhood optic chiasm gliomas: radiographic response following radiotherapy and long-term clinical outcome.
    Tao ML, Barnes PD, Billett AL, Leong T, Shrieve DC, Scott RM, Tarbell NJ.
    Int J Radiat Oncol Biol Phys; 1997 Oct 01; 39(3):579-87. PubMed ID: 9336136
    [Abstract] [Full Text] [Related]

  • 16. Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study.
    Mahoney DH, Cohen ME, Friedman HS, Kepner JL, Gemer L, Langston JW, James HE, Duffner PK, Kun LE.
    Neuro Oncol; 2000 Oct 01; 2(4):213-20. PubMed ID: 11265230
    [Abstract] [Full Text] [Related]

  • 17. Optic pathway gliomas in children with and without neurofibromatosis 1.
    Czyzyk E, Jóźwiak S, Roszkowski M, Schwartz RA.
    J Child Neurol; 2003 Jul 01; 18(7):471-8. PubMed ID: 12940652
    [Abstract] [Full Text] [Related]

  • 18. Visual outcome following chemotherapy for progressive optic pathway gliomas.
    Shofty B, Ben-Sira L, Freedman S, Yalon M, Dvir R, Weintraub M, Toledano H, Constantini S, Kesler A.
    Pediatr Blood Cancer; 2011 Sep 01; 57(3):481-5. PubMed ID: 21241008
    [Abstract] [Full Text] [Related]

  • 19. Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials.
    North K, Cochineas C, Tang E, Fagan E.
    Pediatr Neurol; 1994 Mar 01; 10(2):117-23. PubMed ID: 8024659
    [Abstract] [Full Text] [Related]

  • 20. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Gnekow AK, Kortmann RD, Pietsch T, Emser A.
    Klin Padiatr; 2004 Mar 01; 216(6):331-42. PubMed ID: 15565548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.